Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Leukocyte L1 Antigen Complex | 3 | 2018 | 238 | 1.34 | Why? |
| Weightlessness | 2 | 2018 | 12 | 0.96 | Why? |
| Hepatitis A Virus Cellular Receptor 1 | 2 | 2018 | 86 | 0.84 | Why? |
| Lipocalin-2 | 2 | 2018 | 156 | 0.82 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.65 | Why? |
| Aorta | 1 | 2018 | 355 | 0.59 | Why? |
| Graft Rejection | 3 | 2020 | 1766 | 0.42 | Why? |
| Isometric Contraction | 2 | 2019 | 19 | 0.38 | Why? |
| Pancreas Transplantation | 2 | 2020 | 163 | 0.37 | Why? |
| Kidney Transplantation | 6 | 2020 | 5397 | 0.36 | Why? |
| Graft Survival | 2 | 2018 | 587 | 0.28 | Why? |
| Vascular Stiffness | 2 | 2018 | 264 | 0.28 | Why? |
| Immunity, Humoral | 5 | 2021 | 4849 | 0.27 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.26 | Why? |
| Acute Kidney Injury | 4 | 2018 | 5762 | 0.25 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.24 | Why? |
| Monitoring, Immunologic | 1 | 2020 | 153 | 0.20 | Why? |
| Nephrologists | 1 | 2020 | 117 | 0.19 | Why? |
| Kidney Glomerulus | 1 | 2020 | 144 | 0.19 | Why? |
| Space Flight | 1 | 2018 | 37 | 0.18 | Why? |
| Aerospace Medicine | 1 | 2018 | 47 | 0.18 | Why? |
| Kidney Tubular Necrosis, Acute | 1 | 2017 | 56 | 0.18 | Why? |
| Nephrotic Syndrome | 1 | 2020 | 146 | 0.18 | Why? |
| Vascular Resistance | 1 | 2018 | 148 | 0.17 | Why? |
| Meningoencephalitis | 1 | 2020 | 208 | 0.17 | Why? |
| Lipoproteins, HDL | 1 | 2019 | 154 | 0.17 | Why? |
| Calcineurin Inhibitors | 1 | 2018 | 218 | 0.17 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.17 | Why? |
| Hand Strength | 1 | 2017 | 202 | 0.16 | Why? |
| Purpura, Thrombotic Thrombocytopenic | 1 | 2021 | 284 | 0.16 | Why? |
| Hyperuricemia | 1 | 2017 | 160 | 0.16 | Why? |
| Immunity, Cellular | 4 | 2021 | 3614 | 0.15 | Why? |
| Immunocompromised Host | 3 | 2021 | 5150 | 0.15 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.15 | Why? |
| False Positive Reactions | 1 | 2020 | 1338 | 0.15 | Why? |
| Urinalysis | 1 | 2017 | 218 | 0.14 | Why? |
| von Willebrand Factor | 1 | 2021 | 668 | 0.14 | Why? |
| Cyclosporine | 1 | 2018 | 449 | 0.14 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.14 | Why? |
| Uric Acid | 1 | 2017 | 285 | 0.13 | Why? |
| Blood Pressure Determination | 1 | 2017 | 450 | 0.13 | Why? |
| Allografts | 1 | 2017 | 761 | 0.13 | Why? |
| Rituximab | 1 | 2021 | 1096 | 0.13 | Why? |
| Blood Pressure | 3 | 2019 | 2198 | 0.12 | Why? |
| Hypertension | 3 | 2019 | 8895 | 0.12 | Why? |
| Biopsy | 2 | 2020 | 2811 | 0.11 | Why? |
| Leukocytes | 1 | 2018 | 1046 | 0.11 | Why? |
| Germany | 4 | 2021 | 9196 | 0.11 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.10 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
| Exercise Therapy | 1 | 2017 | 976 | 0.09 | Why? |
| T-Lymphocytes | 3 | 2021 | 6670 | 0.09 | Why? |
| Exercise | 2 | 2019 | 6771 | 0.09 | Why? |
| ROC Curve | 2 | 2017 | 6024 | 0.09 | Why? |
| Male | 19 | 2021 | 367725 | 0.09 | Why? |
| Biomarkers | 4 | 2019 | 23361 | 0.08 | Why? |
| Transplant Recipients | 2 | 2020 | 4982 | 0.08 | Why? |
| Female | 17 | 2021 | 380317 | 0.08 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.08 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| Postoperative Complications | 2 | 2020 | 5861 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.06 | Why? |
| Humans | 24 | 2021 | 930598 | 0.06 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Cross-Sectional Studies | 6 | 2020 | 53120 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Adult | 13 | 2021 | 244371 | 0.06 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.05 | Why? |
| Case-Control Studies | 2 | 2017 | 17671 | 0.05 | Why? |
| Time Factors | 3 | 2019 | 31397 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Aged | 9 | 2021 | 215776 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Hypergravity | 1 | 2018 | 5 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Methods | 1 | 2017 | 19 | 0.05 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2021 | 867 | 0.04 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.04 | Why? |
| Granulocytes | 1 | 2018 | 140 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2020 | 757 | 0.04 | Why? |
| Furosemide | 1 | 2017 | 99 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2019 | 540 | 0.04 | Why? |
| Pulse Wave Analysis | 1 | 2017 | 221 | 0.04 | Why? |
| Radial Artery | 1 | 2017 | 132 | 0.04 | Why? |
| Antibodies, Viral | 4 | 2021 | 51949 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.04 | Why? |
| Cholesterol, HDL | 1 | 2019 | 439 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| B-Lymphocytes | 2 | 2021 | 4418 | 0.04 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.03 | Why? |
| Renal Dialysis | 2 | 2021 | 4358 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| T-Lymphocyte Subsets | 1 | 2020 | 1387 | 0.03 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Membrane Glycoproteins | 1 | 2020 | 2273 | 0.03 | Why? |
| Young Adult | 2 | 2018 | 93724 | 0.03 | Why? |
| General Practitioners | 1 | 2017 | 568 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.02 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.02 | Why? |
| Decision Support Techniques | 1 | 2017 | 903 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Convalescence | 1 | 2020 | 2829 | 0.02 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2017 | 1530 | 0.02 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.02 | Why? |
| Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
| Antirheumatic Agents | 1 | 2021 | 3023 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2020 | 4545 | 0.02 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.01 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Pneumonia, Viral | 1 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.01 | Why? |
| Adolescent | 1 | 2017 | 86841 | 0.00 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Seibert's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(70)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_